Follow-up in Gynecological Cancer Survivors

Active, not recruitingOBSERVATIONAL
Enrollment

1,100

Participants

Timeline

Start Date

February 21, 2019

Primary Completion Date

March 31, 2024

Study Completion Date

April 30, 2024

Conditions
Gynecologic Cancer
Trial Locations (21)

8036

Medical University of Graz, Graz

11941

King Hussein Cancer Center, Amman

Unknown

ZNA Middelheim, Antwerp

Universitair Ziekenhuis Gent, Ghent

Centre Hospitalier Chretien (CHC) - CHC MontLegia, Liège

ZNA Jan Palfijn, Merksem

Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel

HELIOS Kliniken - Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke, Wuppertal

Ospedale San Gerardo, Monza

"Istituto Nazionale Tumori IRCCS Fondazione G. Pascale", Napoli

Azienda Ospedaliera Ordine Mauriziano di Torino, Torino

Hospital Universitario La Paz, Madrid

Hospital Universitario San Carlos, Madrid

Complejo Hospitalario de Navarra, Pamplona

Hospital Universitario de Salamanca, Salamanca

NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital, Glasgow

NL 6525

Radboudumc - Radboud University Medical Center Nijmegen, Nijmegen

NL 3584 CX

UMC-Academisch Ziekenhuis Utrecht, Utrecht

PL 80 211

Medical University Of Gdansk, Gdansk

CT9 4AN

East Kent Hospitals University NHS Foundation Trust - Queen Elizabeth The Queen Mother Hospita, Margate

NN1 5BD

Northampton General Hospital NHS Trust, Cliftonville

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT03515993 - Follow-up in Gynecological Cancer Survivors | Biotech Hunter | Biotech Hunter